Cargando…

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

BACKGROUND: The use of angiotensin II inhibitors is associated with a low risk of recurrence and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion molecule-1 (VCAM-1) is a key factor in tumor metastasis. METHODS: The effects of angiotensin II and irbesartan (an angiotensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Long-Hai, Sun, Hui-Chuan, Zhu, Xiao-Dong, Zhang, Shi-Zhe, Li, Xiao-Long, Li, Kang-Shuai, Liu, Xue-Feng, Lei, Ming, Li, Yan, Tang, Zhao-You
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940954/ https://www.ncbi.nlm.nih.gov/pubmed/33708834 http://dx.doi.org/10.21037/atm-20-5293

Ejemplares similares

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
por: Zhang, Shi-Zhe, et al.
Publicado: (2021)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

Effects of Irbesartan and Amlodipine Besylate Tablets on the Intestinal Microflora of Rats With Hypertensive Renal Damage
por: Yu, Jing, et al.
Publicado: (2022)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model
por: Liu, Xue-Feng, et al.
Publicado: (2022)

Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice
por: Zhang, Zhen-Zhou, et al.
Publicado: (2013)

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study
por: Parhofer, Klaus G, et al.
Publicado: (2007)

Influence of AGTR1 and ABCB1 Gene Polymorphism on the Curative Effect of Irbesartan
por: Wang, Qiao, et al.
Publicado: (2022)

Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
por: Derosa, Giuseppe, et al.
Publicado: (2010)

Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
por: Flack, J M
Publicado: (2007)

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis
por: Long, Hai-Yi, et al.
Publicado: (2021)

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Effects of Irbesartan Pretreatment on Pancreatic β-Cell Apoptosis in STZ-Induced Acute Prediabetic Mice
por: Chen, Cuihong, et al.
Publicado: (2018)

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
por: Li, Kang-Shuai, et al.
Publicado: (2020)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma
por: Chai, Zong-Tao, et al.
Publicado: (2021)

Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma
por: DUAN, YUN-FEI, et al.
Publicado: (2014)

Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma
por: Chen, Xiaopeng, et al.
Publicado: (2021)

Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis
por: Zhuang, Manjiao, et al.
Publicado: (2019)

3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma
por: Hu, Cong-Li, et al.
Publicado: (2021)

Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells
por: SHI, MIAO-QIAN, et al.
Publicado: (2016)

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
por: Kikuchi, Kiyoshi, et al.
Publicado: (2013)

Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway
por: Hachiya, Kensuke, et al.
Publicado: (2021)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Irbesartan improves arterial compliance more than lisinopril
por: Ali, Khalid, et al.
Publicado: (2009)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Late-Onset Rash from Irbesartan: An Immunological Reaction
por: Cardoso, Bárbara Kong, et al.
Publicado: (2019)

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
por: Wang, Xuewen, et al.
Publicado: (2018)

Alpha-Asarone Protects Endothelial Cells from Injury by Angiotensin II
por: Shi, Hai-Xia, et al.
Publicado: (2014)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Gallic Acid Attenuates Angiotensin II-Induced Hypertension and Vascular Dysfunction by Inhibiting the Degradation of Endothelial Nitric Oxide Synthase
por: Yan, Xiao, et al.
Publicado: (2020)

Prevalence of and risk factors for abnormal left ventricular geometrical patterns in hypertensive subjects administered irbesartan
por: Huang, Cheng, et al.
Publicado: (2021)

p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
por: Dai, Hai-long, et al.
Publicado: (2016)

Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!
por: Tchernev, Georgi, et al.
Publicado: (2019)

Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bs39nr037k4g8vuqodjo33kc5e